UNI - EN REPORT No
UNI - EN REPORT No1/2020
Sopharma AD (the “Company”) notifies that for December 2019 the Company recorded an increase in sales of 16% compared to the same month of 2018, incl. 5% increase in sales for the domestic market and 27% increase in export sales.
In 2019 the revenues from sales of production increased by 9% compared to the same period of 2018, incl. keeping sales in domestic market and 15% increase in export sales.